Location History:
- San Mateo, CA (US) (2022 - 2024)
- Menlo Park, CA (US) (2024)
Company Filing History:
Years Active: 2022-2025
Title: M Cyrus Maher: Innovator in Cancer Detection Technologies
Introduction
M Cyrus Maher is a prominent inventor based in San Mateo, CA, known for his significant contributions to cancer detection technologies. With a total of 10 patents to his name, Maher has been at the forefront of developing innovative solutions that enhance the diagnosis and classification of cancer.
Latest Patents
Among his latest patents is the "Methylation markers and targeted methylation probe panel." This invention provides a cancer assay panel designed for the targeted detection of cancer-specific methylation patterns. The patent outlines methods for designing, making, and utilizing this cancer assay panel for effective cancer diagnosis. Another notable patent is the "Convolutional neural network systems and methods for data classification." This invention focuses on classifying various cancer conditions by utilizing a convolutional neural network architecture. It involves obtaining genotypic data constructs from training subjects and formatting them into vector sets for analysis, ultimately training the network to accurately classify cancer conditions.
Career Highlights
M Cyrus Maher is currently employed at Grail, Inc., where he continues to work on groundbreaking technologies in the field of cancer detection. His expertise and innovative approach have positioned him as a key player in the development of advanced diagnostic tools.
Collaborations
Throughout his career, Maher has collaborated with notable colleagues, including Darya Filippova and Robert Abe Paine Calef. These collaborations have further enriched his work and contributed to the advancement of cancer detection technologies.
Conclusion
M Cyrus Maher is a distinguished inventor whose work in cancer detection technologies has made a significant impact in the medical field. His innovative patents and ongoing contributions continue to pave the way for advancements in cancer diagnosis and treatment.